Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation
Completed
Bayer
Phase 1
2009-11-01
The aim of this study is to investigate the effect of moxifloxacin on the QT interval in
order to gain information on the validity of results that will be collected during another
clinical study testing riociguat in patients with pulmonary arterial hypertension (PATENT-1
study).
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
Terminated
Bayer
Phase 2
2010-11-01
The aim of this study is to assess whether oral Riociguat affects the left ventricular
contractility and relaxation in patients with pulmonary hypertension associated with left
ventricular systolic dysfunction
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Active, not recruiting
Bayer
Phase 2
2010-04-14
The aim of this study is to assess whether increasing oral doses of Riociguat are safe and
improve the well-being, symptoms and outcome in patients with pulmonary hypertension
associated with left ventricular systolic dysfunction
Coronary Vasomotor Response After Riociguat Exposure
Withdrawn
Bayer
Phase 2
2012-05-01
The aim of the study is to assess the effects of intracoronary Riociguat on coronary blood
flow in subjects with coronary artery disease and to compare this effect with the
intracoronary nitroglycerin, a coronary vasodilator widly used to treat patients with
coronary artery disease.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
